159 related articles for article (PubMed ID: 33452608)
1. ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma.
Mason MC; Tran Cao HS
Ann Surg Oncol; 2021 Oct; 28(11):6736-6737. PubMed ID: 33452608
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4809-4810. PubMed ID: 37046130
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.
Macfie R; Cohen N
Ann Surg Oncol; 2023 Aug; 30(8):5035. PubMed ID: 37179272
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Bile Duct Resection-Is It Beneficial for Distal Cholangiocarcinoma?
Ebata T; Jikei K; Mizuno T
Ann Surg Oncol; 2021 Apr; 28(4):2000. PubMed ID: 33094374
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Minority-Serving Hospitals are Associated with Lower Likelihood of Providing NCCN Guideline Compliant Care to Patients with Resectable Cholangiocarcinoma.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2021 Dec; 28(13):8172-8173. PubMed ID: 34018087
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Laparoscopic Resection of the Middle Bile Duct for Cholangiocarcinoma: How We Do It (with Video).
Huang J; Xu D; Li A
Ann Surg Oncol; 2024 Feb; 31(2):1278-1279. PubMed ID: 37952020
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.
Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3738-3739. PubMed ID: 32314152
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Use of Machine Learning to Identify Patients with Intrahepatic Cholangiocarcinoma Who Could Benefit More from Neoadjuvant Therapies.
Tsilimigras DI; Mehta R; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1120-1121. PubMed ID: 31712926
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Extreme Liver Surgery for Intrahepatic Cholangiocarcinoma: To be or Not to be Resected, that is the Question.
Lopez-Lopez V; Robles-Campos R
Ann Surg Oncol; 2023 Feb; 30(2):766-767. PubMed ID: 36479664
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma-Opportunities and Challenges.
Dai YS; Gao W; Hu HJ; Jin YW; Li FY
Ann Surg Oncol; 2024 May; 31(5):3104-3105. PubMed ID: 38289446
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Lymphadenectomy for Intrahepatic Cholangiocarcinoma-Predictors, Patterns, and Prognostic Impact.
Moazzam Z; Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):1978-1979. PubMed ID: 36611066
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.
Turner KM; Wilson GC
Ann Surg Oncol; 2022 Aug; 29(8):5103-5104. PubMed ID: 35482267
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.
Choi WJ; Sapisochin G; O'Kane GM
Ann Surg Oncol; 2023 Jun; 30(6):3864-3865. PubMed ID: 36752965
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis.
Spolverato G; Lorenzoni G; Pawlik TM
Ann Surg Oncol; 2022 Nov; 29(12):7642-7643. PubMed ID: 35831525
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.
Alaimo L; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5416-5417. PubMed ID: 37222944
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Impact of Tumor Necrosis on Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2022 May; 29(5):2975-2976. PubMed ID: 35217976
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
Tsilimigras DI; Paredes AZ; Pawlik TM
Ann Surg Oncol; 2020 Dec; 27(13):5233-5234. PubMed ID: 32591955
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Is Major Hepatopancreatoduodenectomy Beneficial for Patients with Advanced and Widespread Extrahepatic Cholangiocarcinoma?
Shimizu A; Soejima Y
Ann Surg Oncol; 2021 Apr; 28(4):2026-2027. PubMed ID: 33084991
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.
Eguchi S; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Sep; 30(9):5429-5430. PubMed ID: 37273026
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.
Endo Y; Moazzam Z; Lima HA; Pawlik TM
Ann Surg Oncol; 2023 Apr; 30(4):2033-2034. PubMed ID: 36396871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
